ZA951576B - Benzodioxane compounds process for their preparation and the pharmaceutical compositions which contain them - Google Patents

Benzodioxane compounds process for their preparation and the pharmaceutical compositions which contain them

Info

Publication number
ZA951576B
ZA951576B ZA951576A ZA951576A ZA951576B ZA 951576 B ZA951576 B ZA 951576B ZA 951576 A ZA951576 A ZA 951576A ZA 951576 A ZA951576 A ZA 951576A ZA 951576 B ZA951576 B ZA 951576B
Authority
ZA
South Africa
Prior art keywords
substd
opt
phenyl
alkyl
contain
Prior art date
Application number
ZA951576A
Other languages
English (en)
Inventor
Gilbert Lavielle
Patrick Hautefaye
Olivier Muller
Mark Millan
Mauricette Brocco
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA951576B publication Critical patent/ZA951576B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA951576A 1994-02-25 1995-02-24 Benzodioxane compounds process for their preparation and the pharmaceutical compositions which contain them ZA951576B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9402161A FR2716680B1 (fr) 1994-02-25 1994-02-25 Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA951576B true ZA951576B (en) 1995-12-12

Family

ID=9460423

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951576A ZA951576B (en) 1994-02-25 1995-02-24 Benzodioxane compounds process for their preparation and the pharmaceutical compositions which contain them

Country Status (17)

Country Link
US (1) US5500443A (da)
EP (1) EP0669331B1 (da)
JP (1) JP2959987B2 (da)
CN (1) CN1064964C (da)
AT (1) ATE196904T1 (da)
AU (1) AU681740B2 (da)
CA (1) CA2143252C (da)
DE (1) DE69519047T2 (da)
DK (1) DK0669331T3 (da)
ES (1) ES2153019T3 (da)
FI (1) FI950817A7 (da)
FR (1) FR2716680B1 (da)
GR (1) GR3035082T3 (da)
NO (1) NO308604B1 (da)
NZ (1) NZ270565A (da)
PT (1) PT669331E (da)
ZA (1) ZA951576B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735129B1 (fr) * 1995-06-07 1997-07-11 Adir Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2762598A1 (fr) * 1997-04-25 1998-10-30 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HK1040055B (zh) * 1998-05-22 2005-04-01 伊莱利利公司 奥氮平和氟西汀在制备治疗对抗治疗的严重抑郁症的药物中的应用
US6960577B2 (en) * 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
GT200600159A (es) * 2005-04-22 2007-03-14 Derivados benzodioxano y benzodioxolano y usos de los mismos
US20090069267A1 (en) * 2006-01-17 2009-03-12 Abrams Daniel J Central administration of stable formulations of therapeutic agents for cns conditions
CL2007003044A1 (es) * 2006-10-24 2008-07-04 Wyeth Corp Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
AU2008279636A1 (en) * 2007-07-25 2009-01-29 The Regents Of The University Of Colorado Central administration of stable formulations of therapeutic agents for CNS conditions
CN102675302B (zh) * 2011-03-17 2014-06-11 南京大学 含1,4-苯并二噁烷的噻二唑衍生物及其制法与其抗菌活性
CN102690261B (zh) * 2011-03-25 2015-02-25 南京大学 含1,4-苯并二噁烷的1,3,4-噁二唑衍生物的制法及其在抗癌药物中应用
CN102746286B (zh) * 2012-07-25 2015-07-15 山东理工大学 苯并二噁唑及其制备方法
CN104311547A (zh) * 2014-09-15 2015-01-28 湖南华腾制药有限公司 一种噻唑衍生物的制备方法
CN104327065A (zh) * 2014-09-15 2015-02-04 湖南华腾制药有限公司 一种n-甲基-(喹啉-4-基)甲烷胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124598A (en) * 1962-10-02 1964-03-10 Aminoalkoxy substituted benzodioxanes
US3345364A (en) * 1964-05-06 1967-10-03 Janssen Pharmaceutica Nv Benzimidazolinyl piperidines
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03264528A (ja) * 1990-03-14 1991-11-25 Mitsubishi Kasei Corp 抗不安薬

Also Published As

Publication number Publication date
GR3035082T3 (en) 2001-03-30
US5500443A (en) 1996-03-19
NZ270565A (en) 1995-12-21
CA2143252C (fr) 2002-04-16
FI950817A0 (fi) 1995-02-22
CN1064964C (zh) 2001-04-25
DE69519047T2 (de) 2001-05-10
EP0669331B1 (fr) 2000-10-11
AU681740B2 (en) 1997-09-04
JP2959987B2 (ja) 1999-10-06
PT669331E (pt) 2001-01-31
DK0669331T3 (da) 2001-02-12
NO950712L (no) 1995-08-28
DE69519047D1 (de) 2000-11-16
NO308604B1 (no) 2000-10-02
EP0669331A1 (fr) 1995-08-30
FI950817A7 (fi) 1995-08-26
ES2153019T3 (es) 2001-02-16
NO950712D0 (no) 1995-02-24
CA2143252A1 (fr) 1995-08-26
FR2716680A1 (fr) 1995-09-01
FR2716680B1 (fr) 1996-04-05
JPH0841046A (ja) 1996-02-13
CN1120041A (zh) 1996-04-10
HK1013291A1 (en) 1999-08-20
ATE196904T1 (de) 2000-10-15
AU1344895A (en) 1995-09-07

Similar Documents

Publication Publication Date Title
AU1344895A (en) New benzodioxane compounds, process for their preparation and the pharmaceutical compositions which contain them
AU669032B2 (en) New indole, indazole and benzisoxazole compounds, process for preparing them and pharmaceutical compositions containing them
AU5062996A (en) Novel pyridine compounds, processes for their preparation and the pharmaceutical compositions which contain them
ES8405782A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
HUT40668A (en) Process for preparing new benzoxazole and amine derivatives and pharmaceutical compositions containing such compounds
HU9700992D0 (en) New 3-(piperid-4-yl)1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, process for their preparation and pharmaceutical compositions containing them
IL79841A (en) 2,3-dihydro-1,3,4-thiadiazole 2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
SE8403801L (sv) Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem
PT87578A (pt) Process for the preparation of new alkanesulfonanilide derivatives and of pharmaceutical composition comprising the same
AU2482695A (en) New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
AU1498895A (en) Novel aminoalkyl benzoazolinones and benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
AU6359198A (en) New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
AU609377B2 (en) New derivaties of 4-OH quinoline carboxylic acid substituted in position 2 by a possibly etherified or esterified dihydroxyl group, the process and intermediates for preparation, their application as medicaments and the compositions containing them
DE3472104D1 (en) N-substituted ûbis(hydroxymethyl)-methyl¨-isoquinoline derivatives, process for preparing them and pharmaceutical compositions containing them
SE8406046D0 (sv) New azabiocyclic compounds and a process for the preparation thereof
FI950681A0 (fi) Uudent akronysiinianalogit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
TW260658B (da)
FI823732L (fi) Nya 1-furyl-3,4-dihydroisokinoliner, laekemedel innehaollande dessa samt deras framstaellningsfoerfaranden och deras anvaendning
AU1494295A (en) Novel aminoalkyl benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them
JO1825B1 (en) Therapeutic agents
MX9703074A (es) Inhibidores de sintesis de apoliproteina-b.
ES2015040B3 (es) Nuevos derivados de pregnano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.